So That's What "Non-Interference" Means: CMS Defines Loaded Term in Proposed Part D Rule
This article was originally published in RPM Report
The 700-page Part D proposed rule does much more than change the "protected" class list. Among many other provisions, it spells out how CMS interprets the infamous "non-interference" clause.
You may also be interested in...
Investors remain hyper-sensitive to any threat to pricing flexibility for biotech products. The latest over-reaction – to a renewed call for Medicare “price negotiation” – meant missing some of the more meaningful messages coming from Washington about support for innovation.
CMS’ final rule on Part D is much narrower than the agency’s proposed rule—and most in industry are probably pleased by that. But it is also much more one-sided, emphasizing new tools to monitor for and correct “abusive” prescribing, without any countervailing provisions reflecting the value of appropriate medication adherence.
The Centers for Medicare & Medicaid Services is celebrating the 10th anniversary of Part D by proposing the most sweeping changes to the Medicare drug benefit since it launched. Proposed revisions to the “Protected Classes” will get the most attention, but the rest of the rule may have more profound impacts going forward.